Skip to main content
. 2012 May 21;17(5):6071–6082. doi: 10.3390/molecules17056071

Table 2.

The inhibition zone diameter (in mm) of pyranocycloartobiloxanthone A (1), dihydroartoindonesianin C (2) and pyranocycloartobiloxanthone B (3) against pathogenic microbes.

Microorganisms Inhibition zone diameter (in mm)
(1) (2) (3) Gentamicin sulfate Streptomycin sulfate Nystatin
Bacteria
Reference strains
  Bacillus subtilis ATCC6633 8 - - 15 nt
  Escherichia coli ATCC25922 7 - - 25 nt
  Micrococcus luteus ATCC10240 - - - nt nt
  Methicillin resistant Staphylococcus aureus ATCC33591 20 - - nt 20
  Pseudomonas aeruginosa JCM2412 - nt nt 15 21
  Staphylococcus aureus ATCC6538 9 - - 11 nt
  Salmonella typhimurium S865B (IMR culture) 9 - - nt nt
Clinically isolated strain
  Bacillus subtilis
12 nt nt nt -
Fungi
Reference strains
  Aspergillus niger ATCC16404 - - - nt
  Candida albican ATCC1023 7 - - 15
  Saccharomyces cerevisiae S617 (IMR culture) 8 - - 23

Note: (-) – not active, (nt) – not tested. Streptomycin sulfate 10 μg/disc, gentamicin sulfate 10 μg/disc, nystatin 100 IU/disc; pyranocycloartobiloxanthone A (1), dihydroartoindonesianin C (2), pyranocycloartobiloxanthone B (3).